XML 49 R39.htm IDEA: XBRL DOCUMENT v3.25.1
Collaboration Agreements, License Agreement and Revenues - Roll-forward of Related Contract Liabilities (Detail)
$ in Thousands
3 Months Ended
Mar. 31, 2025
USD ($)
AstraZeneca Agreements [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2024 $ (132,097)
Additions (35,363)
Recognized as Revenue (Discontinued Operations) 36,863
Currency Translation and Other (248)
Balance at March 31, 2025 (130,845)
Drug Product Revenue, Net [Member] | Astellas Agreement [Member] | Europe [Member]  
Contract with Customer Liability [Line Items]  
Balance at December 31, 2024 (9,901)
Recognized as Revenue 814
Reclassified to Accrued Liability / Accounts Payable 2,076
Balance at March 31, 2025 $ (7,011)